Eisai
4523.T
#1953
Rank
A$12.99 B
Marketcap
$46.09
Share price
1.30%
Change (1 day)
-29.46%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.26

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.45. In 2022 the company made an earnings per share (EPS) of $2.53 a decrease over its 2021 EPS that were of $11.25.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.2628.64%
2022$2.53-77.48%
2021$11.25-41.88%
2020$19.35-0.94%
2019$19.5452.59%
2018$12.80124.17%
2017$5.71-49.42%
2016$11.2937.08%
2015$8.24-11.75%
2014$9.33-3.23%
2013$9.65-18.56%
2012$11.84-15.51%
2011$14.02-3.75%
2010$14.57-1.36%
2009$14.77